On Tuesday, Johnson & Johnson (JNJ) stock saw a decline, ending the day at $152.64 which represents a decrease of $-2.40 or -1.55% from the prior close of $155.04. The stock opened at $154.53 and ...
Johnson & Johnson has sued a U.S. government agency over a closely watched dispute focusing on payment methods for some ...
J&J wants to appoint lawyer Randi Ellis, who helped it prepare for its third talc-related chapter 11 filing, but the U.S.
Johnson & Johnson shows strong progress in oncology with Darzalex sales and regulatory filings, leading to a 'Buy' rating ...
Johnson & Johnson has a high three-year median payout ratio of 71% (or a retention ratio of 29%), meaning that the company is ...
In trading on Monday, shares of Johnson & Johnson entered into oversold territory, hitting an RSI reading of 29.5 ...
Johnson & Johnson’s rebate model aims to address misuse of 340B Program. HRSA’s threats of penalties led J&J to halt the plan, prompting a legal battle to protect its proposed changes. Johnson & ...
WASHINGTON — Speaker Mike Johnson is beginning the hard fight for his gavel, a weeks-long campaign that starts Wednesday ...
Johnson & Johnson MedTech announced today that the FDA granted its Ottava surgical robot investigational device exemption ...
WASHINGTON (AP) — House Speaker Mike Johnson won the House Republican nomination Wednesday to stay on the job, on track to ...
Axios Sneak Peek on MSN4h
Mike Johnson wins GOP nod to remain House speaker with Trump's backingHouse Speaker Mike Johnson (R-La.) won the GOP nomination Wednesday for a full, two-year term in the top job, after running ...
The young defensive tackle is consistently showing why he was a first-round pick last year. Subscribe now to unlock nonstop ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback